X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9366) 9366
Publication (570) 570
Newsletter (124) 124
Magazine Article (65) 65
Book Review (42) 42
Book Chapter (31) 31
Newspaper Article (25) 25
Book / eBook (6) 6
Conference Proceeding (6) 6
Dissertation (3) 3
Web Resource (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5651) 5651
male (4670) 4670
female (3459) 3459
animals (3174) 3174
index medicus (2884) 2884
urea (2654) 2654
blood urea nitrogen (2534) 2534
middle aged (2192) 2192
adult (2126) 2126
creatinine - blood (1806) 1806
rats (1728) 1728
urea - therapeutic use (1586) 1586
aged (1493) 1493
urea - blood (1247) 1247
urea - analogs & derivatives (1202) 1202
pharmacology & pharmacy (1067) 1067
mice (990) 990
time factors (811) 811
adolescent (791) 791
kidney - drug effects (791) 791
oxidative stress (650) 650
kidney - pathology (646) 646
creatinine (636) 636
treatment outcome (626) 626
rodents (569) 569
rats, wistar (553) 553
research article (550) 550
child (548) 548
medicine (544) 544
kidneys (517) 517
urea - metabolism (517) 517
analysis (514) 514
health aspects (505) 505
rats, sprague-dawley (503) 503
kidney - metabolism (500) 500
urology & nephrology (492) 492
disease models, animal (482) 482
inflammation (478) 478
liver (478) 478
research (475) 475
proteins (463) 463
urea - pharmacology (441) 441
metabolism (427) 427
enzymes (412) 412
care and treatment (408) 408
multidisciplinary sciences (407) 407
drug therapy, combination (391) 391
toxicology (390) 390
dose-response relationship, drug (380) 380
urea - administration & dosage (379) 379
antioxidants (364) 364
drug combinations (362) 362
toxicity (360) 360
apoptosis (358) 358
helicobacter pylori (356) 356
anti-bacterial agents - therapeutic use (347) 347
medicine, research & experimental (347) 347
surgery (345) 345
science (342) 342
blood (340) 340
helicobacter infections - drug therapy (338) 338
expression (336) 336
child, preschool (331) 331
mortality (331) 331
prospective studies (328) 328
body weight (324) 324
kidney function tests (323) 323
risk factors (312) 312
therapy (309) 309
clinical trials as topic (307) 307
peroxides - therapeutic use (306) 306
nephrotoxicity (305) 305
transplantation (305) 305
article (303) 303
diabetes (303) 303
kidney (303) 303
biochemistry & molecular biology (301) 301
chemistry, medicinal (301) 301
kidney diseases (300) 300
gastroenterology & hepatology (299) 299
medicine, general & internal (290) 290
immunology (289) 289
follow-up studies (288) 288
administration, oral (287) 287
cancer (287) 287
physiology (285) 285
physiological aspects (284) 284
urine (284) 284
kidney diseases - chemically induced (283) 283
potassium - blood (278) 278
aged, 80 and over (274) 274
blood pressure - drug effects (271) 271
infant (268) 268
studies (268) 268
biochemistry (267) 267
oxidative stress - drug effects (264) 264
disease (263) 263
retrospective studies (262) 262
breath tests (250) 250
glucose (249) 249
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (4) 4
Online Resources - Online (2) 2
Gerstein Science - Periodical Stacks (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Mt Sinai Hospital - Online (1) 1
Scarborough Hospital - Birchmount (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8659) 8659
German (322) 322
French (131) 131
Russian (112) 112
Japanese (75) 75
Italian (71) 71
Chinese (68) 68
Spanish (53) 53
Polish (29) 29
Dutch (15) 15
Swedish (11) 11
Czech (10) 10
Portuguese (10) 10
Danish (8) 8
Korean (5) 5
Ukrainian (5) 5
Bulgarian (4) 4
Norwegian (4) 4
Romanian (4) 4
Hungarian (3) 3
Croatian (2) 2
Hebrew (2) 2
Slovak (2) 2
Finnish (1) 1
Greek (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 06/2010, Volume 11, Issue 3, pp. 157 - 170
Pityriasis rubra pilaris (PRP) is a rare inflammatory dermatosis of unknown etiology, and finding a successful therapy can be challenging. PRP occurs equally... 
Pityriasis-rubra-pilaris, pathogenesis | Pityriasis-rubra-pilaris, treatment | Zidovudine, therapeutic use | Immune-globulin, therapeutic use | Isotretinoin, therapeutic use | Tazarotene, therapeutic use | Efalizumab, therapeutic use | Etretinate, therapeutic use | Photochemotherapy | Infliximab, therapeutic use | Acitretin, therapeutic use | Antiretrovirals, therapeutic use | Etanercept, therapeutic use | Tumour-necrosis-factor-alpha-inhibitors, therapeut | Urea, therapeutic use | Children | Ciclosporin, therapeutic use | Calcipotriol, therapeutic use | Salicylic-acid, therapeutic use | Methotrexate, therapeutic use | Pimecrolimus, therapeutic use | Phototherapy | Adalimumab, therapeutic use | Tretinoin, therapeutic use | Pityriasis-rubra-pilaris, diagnosis | Azathioprine, therapeutic use | Fumaric-acid, therapeutic use | Immunosuppressants, therapeutic use | Retinoids, therapeutic use | Stanozolol, therapeutic use | Corticosteroids, therapeutic use | Keratolytics, therapeutic use | Pharmacotherapy | Medicine & Public Health | Pharmacology/Toxicology | Dermatology | Antiretrovirals | Acitretin | Corticosteroids | Calcipotriol | Ciclosporin | Efalizumab | Adalimumab | Azathioprine | Therapeutic use | EXTRACORPOREAL PHOTOCHEMOTHERAPY | INITIAL PRESENTATION | CUTANEOUS MANIFESTATION | FOCAL ACANTHOLYTIC DYSKERATOSIS | ACITRETIN THERAPY | TOPICAL TREATMENT | ULTRAVIOLET-B | FOLLOW-UP | HUMAN-IMMUNODEFICIENCY-VIRUS | RETINOID THERAPY | DERMATOLOGY | Pityriasis Rubra Pilaris - classification | Diagnosis, Differential | Biopsy | Humans | Dermatologic Agents - therapeutic use | Pityriasis Rubra Pilaris - diagnosis | Pityriasis Rubra Pilaris - therapy | Pityriasis Rubra Pilaris - etiology | Administration, Topical | Skin - pathology | Care and treatment | Pityriasis rosea | Diagnosis | Research
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10058, pp. 2355 - 2365
Summary Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-day triple therapy for the first-line treatment of Helicobacter... 
Internal Medicine | CLARITHROMYCIN | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EFFICACY | GASTRIC-CANCER | RESISTANCE | SEQUENTIAL THERAPY | INFECTION | ERADICATION | METRONIDAZOLE | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Proton Pump Inhibitors - administration & dosage | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Organometallic Compounds - therapeutic use | Female | Urea - metabolism | Amoxicillin - administration & dosage | Lansoprazole - administration & dosage | Drug Administration Schedule | Metronidazole - administration & dosage | Breath Tests | Tetracycline - therapeutic use | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Amoxicillin - therapeutic use | Taiwan | Drug Therapy, Combination - statistics & numerical data | Lansoprazole - therapeutic use | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Organometallic Compounds - administration & dosage | Clinical trials | Medical colleges | Helicobacter infections | Care and treatment | Helicobacter pylori | Antiulcer drugs | Analysis | Bacteria | Bacterial infections | Antibiotics | Drug resistance | Drug therapy
Journal Article
Journal Article
Helicobacter, ISSN 1083-4389, 12/2013, Volume 18, Issue 6, pp. 459 - 467
Background Increasing clarithromycin resistance reduces Helicobacter pylori eradication rates with conventional triple regimens. We evaluated effectiveness and... 
H. pylori treatment | concomitant therapy | first line | dual resistance | clarithromycin resistance | second line | Second line | First line | Concomitant therapy | Dual resistance | Clarithromycin resistance | QUADRUPLE CONCOMITANT THERAPY | EFFICACY | H | ANTIBIOTIC-RESISTANCE | RANDOMIZED-TRIAL | MICROBIOLOGY | SEQUENTIAL THERAPY | pylori treatment | CONSENSUS REPORT | STANDARD TRIPLE THERAPY | LEVOFLOXACIN | INFECTION | 1ST-LINE | GASTROENTEROLOGY & HEPATOLOGY | Prospective Studies | Humans | Middle Aged | Drug Resistance, Bacterial | Helicobacter pylori - drug effects | Male | Clarithromycin - therapeutic use | Esomeprazole - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Amoxicillin - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Helicobacter pylori - physiology | Drug Therapy, Combination | Helicobacter Infections - microbiology | Urea | Proton pump inhibitors | Clarithromycin | Helicobacter pylori | Amoxicillin | Helicobacter Infections/drug therapy | Amoxicillin/therapeutic use | Helicobacter Infections/microbiology | Helicobacter pylori/physiology | Metronidazole/therapeutic use | Bacteriology | Helicobacter pylori/drug effects | Life Sciences | Clarithromycin/therapeutic use | Microbiology and Parasitology | Esomeprazole/therapeutic use | Anti-Bacterial Agents/therapeutic use
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2012, Volume 122, Issue 4, pp. 1541 - 1552
Patients with triple-negative breast cancer (TNBC) - defined by lack of estrogen receptor and progesterone receptor expression as well as lack of human... 
SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | P53 MUTATION | CHECKPOINT KINASE-1 | PATHWAY | PROTEIN-KINASE | 7-HYDROXYSTAUROSPORINE UCN-01 | DNA-DAMAGE | S-PHASE | PREDICTIVE-VALUE | CDC25A PHOSPHATASE | Thiophenes - therapeutic use | Apoptosis - drug effects | Humans | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Receptors, Progesterone - genetics | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Camptothecin - administration & dosage | Antineoplastic Agents, Phytogenic - therapeutic use | Camptothecin - analogs & derivatives | Thiophenes - pharmacology | Tumor Suppressor Protein p53 - deficiency | Breast Neoplasms - drug therapy | DNA, Neoplasm - drug effects | Protein Kinase Inhibitors - administration & dosage | Urea - therapeutic use | Mice, Inbred NOD | Mice | DNA Damage | Cell Cycle - drug effects | Genes, cdc | Staurosporine - pharmacology | Urea - pharmacology | Staurosporine - administration & dosage | Neoplasm Proteins - physiology | Staurosporine - analogs & derivatives | Cell Line, Tumor - transplantation | Receptors, Estrogen - analysis | Thiophenes - administration & dosage | Molecular Targeted Therapy | Genes, p53 | Urea - analogs & derivatives | Female | Antineoplastic Agents - pharmacology | Cell Line, Tumor - metabolism | Urea - administration & dosage | Protein Kinases - drug effects | Receptors, Estrogen - genetics | Camptothecin - therapeutic use | Mice, SCID | Xenograft Model Antitumor Assays | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Genes, erbB-2 | Protein Kinase Inhibitors - therapeutic use | Staurosporine - therapeutic use | Protein Kinases - physiology | Checkpoint Kinase 1 | Neoplasm Proteins - analysis | Protein Kinase Inhibitors - pharmacology | Breast cancer | Genetic aspects | Research | Gene mutations | Health aspects | DNA damage | Estrogen | Càncer de mama | Ratolins (Animals de laboratori) | Apoptosi | Receptors d'hormones | Hormone receptors | Chemotherapy | Mice (Laboratory animals) | Progesterone | Quimioteràpia | Progesterona | Estrògens | Apoptosis
Journal Article